← All indications
Amphetamine-Related Disorders
Disorders related or resulting from use of amphetamines.
Drugs by status
Phase 3 trials (6)
Phase 2 trials (8)
Phase 1 trials (13)
Other trials (3)
Organizations
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (14)
- New River Pharmaceuticals
- Alkermes
- Friends Research Institute, Inc.
- Johns Hopkins University
- University of California, Los Angeles
- University of California, San Francisco
- University of Montreal
- Insys Therapeutics Inc
- University of New South Wales
- Department of Veteran Affairs
- City of San Francisco
- Government of Australia
- Sydney Hospital
- The University of Texas, Dallas
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (4)